Normothermic Machine-perfused Human Donor Livers Produce Functional Hemostatic Proteins

被引:1
|
作者
Bodewes, Silke B. [1 ,2 ]
Lascaris, Bianca [1 ,2 ]
Adelmeijer, Jelle [1 ]
de Meijer, Vincent E. [2 ]
Porte, Robert J. [1 ]
Lisman, Ton [1 ,2 ,3 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Surg Res Lab, Groningen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Sect Hepatobiliary Surg & Liver Transplantat, Groningen, Netherlands
[3] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Surg Res Lab, Hanzepl 1, NL-9713 GZ Groningen, Netherlands
关键词
NONANASTOMOTIC BILIARY STRICTURES; TRANSPLANTATION; RISK; DONATION; DISEASE;
D O I
10.1097/TP.0000000000004670
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Normothermic machine perfusion (NMP) is used for the viability assessment of high-risk donor livers before transplantation. The production of hemostatic proteins is one of the major synthetic functions of the liver. The objective of this study was to measure the concentration and functionality of hemostatic proteins concentration in the NMP perfusate of human donor livers. Methods. Thirty-six livers that underwent NMP for viability assessment were included in this study. Perfusate samples taken during NMP (start, 150 min, and 300 min) were used for the measurement of antigen and activity levels of hemostatic proteins (factors II, VII, and X; fibrinogen; plasminogen; antithrombin; tissue plasminogen activator; von Willebrand factor; and proteins induced by vitamin K absence). The antigen levels were correlated with hepatocellular function according to previously proposed individual hepatocellular viability criteria: lactate clearance and perfusate pH. Results. Antigen levels of hemostatic proteins reached subphysiological levels in the NMP perfusate. Hemostatic proteins that were produced during NMP were at least partially active. All livers produced all hemostatic proteins tested within 150 min of NMP. Hemostatic protein concentrations did not significantly correlate with perfusate lactate and perfusate pH after 150 min of NMP. Conclusions. All livers produce functional hemostatic proteins during NMP. The generation of a functional hemostatic system in NMP perfusate confirms the need for adequate anticoagulation of the perfusate to avoid generation of (micro)thrombi that may harm the graft.
引用
收藏
页码:2377 / 2383
页数:7
相关论文
共 50 条
  • [41] One hundred normothermic machine perfused DBD livers grafts with intention to transplant: donor risk scores do not predict transplantable grafts
    Hann, A.
    Nutu, A.
    Lembach, H.
    Patel, I.
    Clarke, G.
    Duran, M.
    Sneiders, D.
    Hartog, H.
    Perera, T.
    TRANSPLANTATION, 2022, 106 (8S) : 35 - 35
  • [42] The Delivery of Multipotent Adult Progenitor Cells to Extended Criteria Human Donor Livers Using Normothermic Machine Perfusion
    Laing, Richard W.
    Stubblefield, Samantha
    Wallace, Lorraine
    Roobrouck, Valerie D.
    Bhogal, Ricky H.
    Schlegel, Andrea
    Boteon, Yuri L.
    Reynolds, Gary M.
    Ting, Anthony E.
    Mirza, Darius F.
    Newsome, Philip N.
    Mergental, Hynek
    Afford, Simon C.
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [43] Criteria for Viability Assessment of Discarded Human Donor Livers During Ex-Vivo Normothermic Machine Perfusion
    Karimian, N.
    Sutton, M.
    op den Dries, S.
    de Boer, M.
    Wiersema-Buist, J.
    Gouw, A.
    Leuvenink, H.
    Lisman, T.
    Porte, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 345 - 345
  • [44] Criteria for Viability Assessment of Discarded Human Donor Livers During Ex-Vivo Normothermic Machine Perfusion
    Karimian, N.
    Sutton, M.
    op den Dries, S.
    de Boer, M.
    Wiersema-Buist, J.
    Gouw, A.
    Leuvenink, H.
    Lisman, T.
    Porte, R.
    TRANSPLANTATION, 2014, 98 : 345 - 345
  • [45] Computational Modeling of Sodium Fluorescein Disposition in Ex Vivo, Machine-Perfused Livers with Ischemia-Reperfusion Injury
    Monti, Christopher
    Audi, Said
    Hong, Seung-Keun
    Yang, Yongqiang
    Kim, Joohyun
    Dash, Ranjan
    PHYSIOLOGY, 2024, 39
  • [46] The international normalised ratio to monitor coagulation factor production during normothermic machine perfusion of human donor livers
    Van den Boom, Bente P.
    Bodewes, Silke B.
    Lascaris, Bianca
    Adelmeijer, Jelle
    Porte, Robert J.
    de Meijer, Vincent E.
    Lisman, Ton
    THROMBOSIS RESEARCH, 2023, 228 : 64 - 71
  • [47] Successful Ex-Vivo Normothermic Machine Perfusion and Viability Testing of Discarded Human Donor Livers.
    den Dries, Sanna Op
    Karimian, Negin
    Sutton, Michael E.
    Westerkamp, Andrie C.
    Nijsten, Maarten W. N.
    Gouw, Annet S. H.
    Wiersema-Buist, Janneke
    Lisman, Ton
    Leuvenink, Henri G. D.
    Porte, Robert J.
    LIVER TRANSPLANTATION, 2013, 19 : S114 - S114
  • [48] CRITERIA FOR VIABILITY ASSESSMENT OF DISCARDED HUMAN DONOR LIVERS DURING EX-VIVO NORMOTHERMIC MACHINE PERFUSION
    Sutton, M. E.
    Den Dries, S. Op
    Karimian, N.
    De Boer, M. T.
    Wiersema-Buist, J.
    Gouw, A. S. H.
    Leuvenink, H. G. D.
    Lisman, T.
    Porte, R. J.
    TRANSPLANT INTERNATIONAL, 2014, 27 : 11 - 11
  • [49] Protecting Donor Livers During Normothermic Machine Perfusion With Stem Cell Extracellular Vesicles
    Sharma, Ashish K.
    Laubach, Victor E.
    TRANSPLANTATION, 2018, 102 (05) : 725 - 726
  • [50] Normothermic Machine Perfusion of Donor Livers for Transplantation in the United States A Randomized Controlled Trial
    Chapman, William C.
    Barbas, Andrew S.
    D'Alessandro, Anthony M.
    Vianna, Rodrigo
    Kubal, Chandrashekhar A.
    Abt, Peter
    Sonnenday, Christopher
    Barth, Rolf
    Alvarez-Casas, Josue
    Yersiz, Hasan
    Eckhoff, Devin
    Cannon, Robert
    Genyk, Yuri
    Sher, Linda
    Singer, Andrew
    Feng, Sandy
    Roll, Garrett
    Cohen, Ari
    Doyle, Maria B.
    Sudan, Debra L.
    Al-Adra, David
    Khan, Adeel
    Subramanian, Vijay
    Abraham, Nader
    Olthoff, Kim
    Tekin, Akin
    Berg, Lynn
    Coussios, Constantin
    Morris, Chris
    Randle, Lucy
    Friend, Peter
    Knechtle, Stuart J.
    ANNALS OF SURGERY, 2023, 278 (05) : E912 - E921